[Effects of transdermal buprenorphine in cancer patients. Results from the Cancer Pain Outcome Research (CPOR) Study Group]. / Effetti della somministrazione di buprenorfina transdermica in pazienti oncologici. Risultati di uno studio di outcome.
Recenti Prog Med
; 99(11): 538-51, 2008 Nov.
Article
en It
| MEDLINE
| ID: mdl-19209537
ABSTRACT
Pain still afflicts most cancer patients, mainly in the metastatic phases, and undertreatment is well documented. Transdermal delivery systems (TDS) could potentially have advantages over oral and parental routes, but evidence from comparative trials are scanty. In the framework of a wider initiative, an Outcome Research Study was carried out in Italy in 2006 to evaluate the effects of various analgesic options, particularly TDS Buprenorphine. Despite the limitations due to the observational design, these findings may be useful to clinicians to better judge the value of the drug under evaluation and to help researchers to design further comparative studies.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Buprenorfina
/
Analgésicos Opioides
/
Neoplasias
Tipo de estudio:
Clinical_trials
/
Observational_studies
Límite:
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
Europa
Idioma:
It
Revista:
Recenti Prog Med
Año:
2008
Tipo del documento:
Article